Suvretta Capital Management, Llc

Institutional manager — quarterly 13F holdings, Q ending 2026-03-31

Reported value
$3.92B
Q ending 2026-03-31
Prior quarter
$4.88B
Q ending 2025-12-31
Change
-19.8% QoQ · +45.3% YoY
Positions
89
reported holdings

Largest positions

All 89 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
HoldingTickerTypeValueShares
Arcutis Biotherapeutics IncARQTShares$290.4M12.3M
Veradermics IncMANEShares$263.3M4.2M
State Str Spdr S&P 500 Etf TSPYPut$227.6M350K
Palvella Therapeutics Inc NePVLAShares$143.8M1.2M
Apellis Pharmaceuticals IncAPLSShares$141.5M3.5M
Legend Biotech CorpLEGNShares$137.1M7.6M
Benitec Biopharma IncBNTCShares$123.0M11.5M
Capricor Therapeutics IncCAPRShares$116.1M3.8M
Immatics N.VShares$110.1M11.2M
Arcus Biosciences IncRCUSShares$108.7M5.0M
Eyepoint IncEYPTShares$106.9M8.3M
Arrivent Biopharma IncAVBPShares$101.5M4.4M
Taiwan Semiconductor ManufacTSMShares$100.9M299K
Nvidia CorporationNVDAShares$100.2M575K
Meta Platforms IncMETAShares$97.1M170K
Kalvista Pharmaceuticals Inc4XC1Shares$96.0M4.8M
Ge AerospaceGEShares$88.0M310K
Biohaven LtdShares$87.0M10.3M
Sysco CorpSYYShares$82.7M1.2M
Mgm Resorts InternationalMGMShares$79.9M2.2M
Compass Therapeutics IncCMPXShares$75.7M14.3M
Home Depot IncHDShares$72.9M222K
Kura Oncology IncKURAShares$69.7M8.6M
Monte Rosa Therapeutics IncGLUEShares$69.5M4.2M
Bank America CorpBACShares$63.1M1.3M
Erasca IncERASShares$55.6M3.4M
Capital One Finl CorpCOFShares$55.2M302K
Zura Bio LtdShares$53.9M9.1M
Amazon Com IncAMZNShares$52.9M254K
Advanced Micro Devices IncAMDShares$52.3M257K
Fulcrum Therapeutics IncFULCShares$50.3M6.6M
Vulcan Matls CoVMCShares$49.4M182K
Ferguson Enterprises IncFERGShares$49.4M212K
Apollo Global Mgmt IncAPOShares$43.2M388K
Mineralys Therapeutics IncMLYSShares$41.7M1.5M
Crinetics Pharmaceuticals InCRNXShares$37.9M1.0M
Contineum Therapeutics IncCTNMShares$37.1M2.8M
Us Foods Hldg CorpUSFDShares$36.5M396K
Performance Food Group CoPFGCShares$33.1M387K
Replimune Group IncREPLShares$32.3M4.2M
Advisorshares TrMSOSShares$32.1M9.0M
Aura Biosciences IncAURAShares$29.3M4.4M
Unitedhealth Group IncUNHShares$27.2M101K
Prokidney CorpPROKShares$22.1M12.3M
Life Time Group Holdings IncLTHShares$13.7M510K
Whitehawk Therapeutics IncWHWKShares$12.8M3.7M
Abeona Therapeutics IncABEOShares$12.0M2.7M
Wingstop IncWINGShares$9.2M60K
Molecular Partners AgMOLNShares$8.8M2.2M
Boston Scientific CorpBSXShares$7.8M124K
Lexeo Therapeutics IncLXEOShares$7.2M1.3M
Coherent CorpCOHRShares$7.1M30K
Inflarx NvShares$7.1M7.9M
Danaher Corp DelDHRShares$6.9M36K
Abbott LaboratoriesABTShares$6.9M67K
Thermo Fisher Scientific IncTMOShares$6.6M13K
Medtronic PlcShares$6.3M72K
Johnson & JohnsonJNJShares$5.7M23K
Kezar Life Sciences Inc2KZ0Shares$5.3M717K
Intuitive Surgical IncISRGShares$5.2M11K
Anteris Technologies GlobalAVRShares$4.7M850K
Cencora IncCORShares$3.9M12K
Satellos Bioscience IncMSLEShares$2.7M475K
Mettler Toledo InternationalMTDShares$2.5M2K
Natera IncNTRAShares$2.0M10K
Dexcom IncDXCMShares$2.0M32K
Stryker CorporationSYKShares$1.9M6K
Tesla IncTSLAShares$1.9M5K
Talen Energy CorpTLNShares$1.9M6K
Medline IncMDLNShares$1.9M43K
Microsoft CorpMSFTShares$1.8M5K
Mckesson CorpMCKShares$1.6M2K
Hca Healthcare IncHCAShares$1.5M3K
Edwards Lifesciences CorpEWShares$1.5M19K
Iqvia Hldgs IncIQVShares$1.2M7K
Ww Grainger IncGWWShares$1.1M1K
Sensei Biotherapeutics IncFTHShares$1.1M35K
Waters CorpWATShares$960K3K
Vistra CorpVSTShares$902K6K
Ionis Pharmaceuticals IncIONSShares$811K11K
Agilent Technologies IncAShares$569K5K
Resmed IncRMDShares$537K2K
Spotify Technology S AShares$533K1K
Veralto CorpVLTOShares$484K5K
Roblox CorpRBLXShares$476K8K
Sarepta Therapeutics IncSRPTShares$389K18K
Steris PlcShares$338K2K
Viridian Therapeutics IncVRDNShares$327K17K
Zimmer Biomet Holdings IncZBHShares$295K3K

Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.